F 0658
Ensure services provided by the nursing facility meet professional standards of quality.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed ensure the Post Discharge Plan of Care was completed and
contained the amount and lists of post discharge medications, for 1 of 4 sampled residents (Resident 1)
who was discharged to a Board and Care facility ([B&C] a small residential facility, often referred to as a
residential care facility for the elderly (RCFE) or assisted living facility, that provides room, board, and
personal care services for a small group of individuals, typically 6 to 10 residents), as indicated in the
facility ' s policy and procedure (P&P) titled Discharge Summary.
Residents Affected - Few
This failure resulted in Resident 1 being discharged with 78 controlled medications (drug prescription
specifically regulated by the government due to potential for abuse or harm) and placed the resident at risk
for drug overdose, hospitalization and death.
Findings:
During a review of Resident 1 ' s admission Record, the admission Record indicated Resident 1 was
admitted to the facility on [DATE] with diagnoses of Alzheimer ' s disease (progressive mental deterioration
that can occur in middle or old age, due to generalized degeneration of the brain), cardiomegaly (occurs
when the heart is abnormally thick or overly stretched), difficulty walking and a history of falling.
During a review of Resident 1 ' s Minimum Data Set (MDS -a resident assessment tool) dated 2/9/2025, the
MDS indicated Resident 1 had clear speech, had difficulty communicating some words or finishing thoughts
but was able, if prompted or given time, and usually understands. The MDS indicated Resident 1 required
supervision or touching assistance (helper provides verbal cues and/or touching assistance as resident
completes the activity) with eating, oral hygiene, and personal hygiene.
During a review of Resident 1 ' s Order Summary Report, dated 3/1/2025, the order summary report
indicated a physician order of Norco (strong pain medicine) oral tablet 5-325 milligrams ([mg] a unit of
measurement), give 1 tablet by mouth every 4 hours as needed for moderate pain (4-6) (a numerical pain
scale used in a facility with 0 no pain, 1-3 mild pain, 4-6 moderate pain, 7-8 severe pain, 9-10 worst pain
possible), and give 2 tablets by mouth every 4 hours as needed for severe pain (7-10).
During a review of Resident 1 ' s Controlled Medication Count Sheet, the count sheet indicated the facility
received 81 tablets of Norco 5-325 mg on 3/30/2025 and dispensed 2 tablets of Norco 5-325 mg on
3/30/2025 for severe pain. The count sheet indicated Norco 5-325 mg 1 tablet was dispensed on 3/31/2025
for moderate pain. The bubble pack (a pack containing medications) had a total of 78 Norco 5-325 mg
tablets left.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 6
Event ID:
056267
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056267
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/22/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Camino Healthcare
13922 Cerise Avenue
Hawthorne, CA 90250
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During a review of Resident 1 ' s physician order dated 4/2/2025, at 9:25 a.m., the physician order indicated
may discharge Resident 1 home per family request on 4/2/2025. The physician order did not indicate the
name of medication or amount of medication to provide upon discharge. The physician order had a printed
date of 2/14/2025, at 10:15 a.m.
During a review of Resident 1 ' s Post Discharge Plan Of Care (DC plan document), dated 4/2/2025, the
DC plan document indicated the discharge planning was developed with the responsible party and
Resident 1 was being transferred to a B&C facility. The medication section of the DC plan document was
left blank indicating See med charts. The DC plan document did not indicate the name of medications,
frequency, special instructions or the amount of medications released. The DC plan document had no name
of the Interdisciplinary Team (IDT) representative who completed the Post Discharge Plan of Care
document, was undated and did not indicate signature who accepted the Post Discharge Plan of Care.
During a review of Resident 1 ' s Transfer/Discharge Report, dated 5/14/2025, the report indicated a list of
Resident 1 ' s current medications and the date and time last of administration. The Transfer/Discharge
Report did not indicate the name and amount of each medication provided to resident/resident family.
During a telephone interview on 5/20/2025 at 1:15 p.m., with Resident 1 ' s family member (FM 1), FM1
stated the B&C facility received 81 tables of Norco several days before Resident 1 was discharged (date
unspecified). FM 1 stated the facility provided 75 tablets of Norco on the day of discharge. FM 1 stated she
felt the facility had committed fraud and was stealing resident ' s narcotics.
During a concurrent interview and record review on 5/22/2025 at 10:55 a.m. with Licensed Vocational Nurse
(LVN 2), Resident 1 ' s physician order dated 4/2/2025, at 9:25 a.m., indicating may discharge Resident 1
home per family request on 4/2/2025 was reviewed. LVN 2 stated there was a new discharge order (date
not known) found that indicated to discharge home with all medications. The newly found discharge order
with all medications did not specify any medications.
During a telephone interview on 5/22/2025 at 3:40 p.m. with Resident 1 ' s attending physician, the
Attending Physician stated he and his Nurse Practitioner were not informed of the medications Resident 1
was discharging home with. The Attending Physician stated he would not discharge Resident 1 home with
Norco because it ' s a narcotic and too harmful.
During a telephone interview on 5/23/2025 at 2 p.m. with the discharging Registered Nurse (RN 1), RN 1
recalled Resident 1 had a physician order to discharge home with all medications. RN 1 was unable to
recall the specific medications and amount of medications Resident 1 was discharged with. RN 1 stated the
normal process of discharging a resident with a narcotic was to indicate amount of narcotic on
Transfer/Discharge Report and Discharge Summary and have the resident sign and date when received.
RN 1 stated the Transfer/Discharge Report and Discharge Summary had inaccurate documentation
because she was in a hurry and did not want Resident 1 and FM waiting. RN 1 stated not indicating the
amount of Norco dispensed during Resident 1 ' s discharge had the potential to cause drug overdose and
respiratory depression which could lead to death.
During a review of the facility ' s P&P titled Discharge Summary, dated 12/2023, the P&P indicated it is the
policy of this facility that a discharge summary be prepared when a resident is expected to be discharged .
The P&P indicated when the facility anticipated a resident ' s discharge, the discharge summary should
include a reconciliation of all pre-discharge medications with the resident ' s
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056267
If continuation sheet
Page 2 of 6
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056267
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/22/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Camino Healthcare
13922 Cerise Avenue
Hawthorne, CA 90250
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
post discharge medications (both prescribed and over the counter).
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056267
If continuation sheet
Page 3 of 6
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056267
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/22/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Camino Healthcare
13922 Cerise Avenue
Hawthorne, CA 90250
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure the Norco (strong pain medicine) medication
removed on 3/1 at 5 p.m., 3/13 at 4 p.m., 3/14 at 9 p.m., and the 2 tablets on 3/18 (no years indicated), as
indicated in the Controlled Medication (drug prescription specifically regulated by the government due to
potential for abuse or harm) Count Sheet dated 8/5/2024, for 1 of 4 sampled residents (Resident 1), were
documented in the resident ' s e-MAR (Electronic Medication Administration Record) .
This failure had the potential to cause drug diversion (unlawful use of drugs), healthcare personnel
miscommunication and cause the resident, drug overdose.
Findings:
During a review of Resident 1 ' s admission Record, the admission Record indicated Resident 1 was
admitted to the facility on [DATE] with diagnoses of Alzheimer ' s disease (progressive mental deterioration
that can occur in middle or old age, due to generalized degeneration of the brain), cardiomegaly (occurs
when the heart is abnormally thick or overly stretched), difficulty walking and a history of falling.
During a review of Resident 1 ' s Minimum Data Set (MDS -a resident assessment tool) dated 2/9/2025, the
MDS indicated Resident 1 had clear speech, difficulty communicating some words or finishing thoughts but
was able, if prompted or given time, and usually understands. The MDS indicated Resident 1 required
supervision or touching assistance (helper provides verbal cues and/or touching assistance as resident
completes the activity) with eating, oral hygiene, and personal hygiene.
During a review of Resident 1 ' s Order Summary Report, dated 3/1/2025, the order summary report
indicated a physician order of Norco oral tablet 5-325 milligram (mg- a unit of measurement), give 1 tablet
by mouth every 4 hours as needed for moderate pain (4-6) (a numerical pain scale used in a facility with 0
no pain, 1-3 mild pain, 4-6 moderate pain, 7-8 severe pain, 9-10 worst pain possible), and give 2 tablets by
mouth every 4 hours as needed for severe pain (7-10).
During a review of Resident 1 ' s Controlled Medication Count Sheet, dated 8/5/2024, the count sheet
indicated a licensed staff removed one tablet of Norco 5/325 mg on 3/1 at 5 p.m. (no year indicated), 3/13
at 4 p.m. (no year indicated), 3/14 at 9 p.m. (no year indicated), and two (2) tablets on 3/18 at 10 p.m. (no
year indicated).
During a review of Resident 1 ' s March 2025 e-MAR, the e-MAR did not indicate Resident 1 received
Norco 5/325 mg, one tablet on 3/1 at 5 p.m., 3/13 at 4 p.m., 3/14 at 9 p.m., and the 2 tablets on 3/18 at 10
p.m.
During a concurrent interview and record review on 5/22/2025 at 10:55 a.m., with the Licensed Vocational
Nurse (LVN 2), Resident 1 ' s Controlled Medication Count Sheet, dated 8/5/2024, for the medication Norco
5/325 mg, and the MAR for March 2025 were reviewed. LVN 2 stated nurses did not sign the e-MAR to
reflect what was removed from the narcotic count sheet. LVN 2 stated not signing the e-MAR may result to
drug overdose, altered level of consciousness and harm the resident.
During a review of the facility ' s policy and procedure (P&P) titled Medication Administration
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056267
If continuation sheet
Page 4 of 6
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056267
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/22/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Camino Healthcare
13922 Cerise Avenue
Hawthorne, CA 90250
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Controlled Medications, dated 5/2020, the P&P indicated when a controlled medication is administered, the
licensed nurse administering the medication should immediately enter all the following information on the
accountability record after the medication is actually administered.
· Date and time of administration.
Residents Affected - Few
· Amount administered.
· Signature of the nurse administering the dose.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056267
If continuation sheet
Page 5 of 6
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056267
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/22/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Camino Healthcare
13922 Cerise Avenue
Hawthorne, CA 90250
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Provide and implement an infection prevention and control program.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to implement its policy and procedure (P&P)
titled Infection Control Policy/Procedure, by failing to disinfect the wrist blood pressure monitor before and
after use, by 1 of 4 sampled residents (Resident 2).
Residents Affected - Few
This failure had the potential to spread germs and increase the risk of infections among residents and staff.
Findings:
During a concurrent observation and interview on 5/14/2025 at 10:05 a.m. with the Licensed Vocational
Nurse (LVN 1) at Resident 2 ' s bedside, LVN 1 was observed putting the wrist blood pressure monitor on
Resident 2 ' s wrist, had several attempts to check and was unsuccessful in obtaining the blood pressure
readings. LVN 1 removed the monitor from the resident ' s wrist, put the blood pressure monitor inside the
drawer of the Medication cart 1 without disinfecting. LVN 1 stated she failed to disinfect the wrist blood
pressure monitor before and after using on the resident. LVN 2 stated failing to disinfect the wrist blood
pressure monitor may spread germs and increase the risk of infection.
During an interview on 5/14/2025 at 1:10 p.m. with the Infection Preventionist Nurse (IPN), the IPN stated
failure to clean the wrist blood pressure monitor before and after use will increase the risk of spreading a
communicable disease to the residents.
During a review of Resident 2 ' s admission Record, the admission Record indicated Resident 2 was
originally admitted to the facility on [DATE] and was re-admitted on [DATE]. Resident 2 ' s diagnoses
included dementia (a condition characterized by progressive or persistent loss of intellectual functioning,
especially with impairment of memory and abstract thinking, and often with personality change), chronic
obstructive pulmonary disease (COPD- is a lung disease that makes it difficult to breathe), and muscle
weakness.
During a review of Resident 2 ' s Minimum Data Set (MDS - resident assessment tool), dated 3/12/2025,
the MDS indicated Resident 2 had clear speech, difficulty communicating some words or finishing thoughts
but is able if prompted or given time, and usually understood. The MDS indicated Resident 2 was
dependent on staff for assistance with eating, toileting hygiene and personal hygiene.
During a review of Resident 2 ' s care plan, no title, date initiated 3/28/2024, the care plan indicated
Resident 2 had actual impairment to skin integrity related to left hip wound infection. The care plan goals
indicated Resident 2 will have no complications related to skin injury/infection. One of the interventions
indicated to avoid scratching and keeping hands and body parts from excessive moisture, keeping
fingernails short, and educate resident/family/caregivers of causative (effective or operating as a cause or
agent) factors and measures to prevent skin injury.
During a review of the facility ' s undated P&P titled, Infection Control Policy/Procedure, the P&P indicated it
is the policy of this facility to provide supplies and equipment that are adequately cleaned, disinfected or
sterilized. The P&P indicated supplies, and equipment should be cleaned immediately after use.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056267
If continuation sheet
Page 6 of 6